PRA International has opened new offices in the Middle East and Eastern Europe to expand the clinical research organization’s capabilities to conduct clinical trials throughout the world.
The new office in Tel Aviv, Israel expands on a presence in Israel that PRA initially established in 2007 through local contractors. Privately held PRA, headquartered in Raleigh, North Carolina, has also opened a new office in the Ukraine. The company said that the Ukraine’s population of nearly 50 million makes it an attractive location for clinical trials.
With the opening of the new offices, PRA now has 39 global offices. In the last year, the CRO has opened offices in Prague, Poland, Budapest and New Zealand. PRA conducts clinical trials in all therapeutic areas in more than 80 countries.